10x Genomics (TXG) Misses Q4 EPS by $3.64, Revenues Beat; Offers FY21 Revenue Mid-Point Guidance Below Consensus
Go back to 10x Genomics (TXG) Misses Q4 EPS by $3.64, Revenues Beat; Offers FY21 Revenue Mid-Point Guidance Below Consensus| IT Group, Inc. (NASDAQ: TXG) | Delayed: 32.24 -0.7 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.94 | 52 Week High | $0.00 | |||
| Open | $31.92 | 52 Week Low | $0.00 | |||
| Day High | $33.36 | P/E | N/A | |||
| Day Low | $31.30 | EPS | $0.00 | |||
| Volume | 1,693,024 | |||||

